2008-11-08 16:11:03 -

www.bio-bridge-science.com - Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company engaged in the commercial development of vaccines for the prevention and treatment of human infectious diseases, announced today that Dr. Liang Qiao, the Company's chief executive officer, will present at the Rodman & Renshaw 10th Annual Healthcare Conference, on Wednesday, November 12, 2008, at 9:30 a.m. Eastern time in the Louis

room at the Palace Hotel, New York City.

The presentation will give an overview of the Company, a summary of its strategic plan, as well as, discuss recent events such as the completion of an acquisition of Xinheng Baide Biotechnology and the execution of a Memorandum of Understanding to form a Joint Venture in China.

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks defined in this document and in statements filed from time to time with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by these cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof. Please refer to the Company's SEC filings for additional information.

Bio-Bridge Science, Inc.
Chris Young, 630-928-0869
cyoung@bio-bridgescience.com